COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021
Reports of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) have been widely published across the world since the onset of the pandemic with varying incidence rates. We retrospectively studied all patients with severe COVID-19 infection who were admitted to our tertiary...
Guardado en:
Autores principales: | Geetha Sivasubramanian, Hebah Ghanem, Michele Maison-Fomotar, Ratnali Jain, Robert Libke |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/022e9c267f2a4d7a835446a59be24154 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit—A Monocentric Retrospective Observational Study
por: Emilien Gregoire, et al.
Publicado: (2021) -
Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang
por: Xuan Zhang, et al.
Publicado: (2021) -
Proteome analysis of bronchoalveolar lavage fluids reveals host and fungal proteins highly expressed during invasive pulmonary aspergillosis in mice and humans
por: Silke Machata, et al.
Publicado: (2020) -
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
por: Giacomo Casalini, et al.
Publicado: (2021) -
Galactomannan antigen as one of the markers for the diagnosis of invasive aspergillosis
por: O.O. Yastremska, et al.
Publicado: (2019)